Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis.
Bertagnolio S, Hermans L, Jordan MR, Avila-Rios S, Iwuji C, Derache A, Delaporte E, Wensing A, Aves T, Borhan ASM, Leenus A, Parkin N, Doherty M, Inzaule S, Mbuagbaw L. Bertagnolio S, et al. J Infect Dis. 2021 Aug 2;224(3):377-388. doi: 10.1093/infdis/jiaa683. J Infect Dis. 2021. PMID: 33202025 Free PMC article. Review.
National prevalence and trends of HIV transmitted drug resistance in Mexico.
Avila-Ríos S, García-Morales C, Garrido-Rodríguez D, Ormsby CE, Hernández-Juan R, Andrade-Villanueva J, González-Hernández LA, Torres-Escobar I, Navarro-Álvarez S, Reyes-Terán G; Mexican HIV Molecular Epidemiology Project Group. Avila-Ríos S, et al. PLoS One. 2011;6(11):e27812. doi: 10.1371/journal.pone.0027812. Epub 2011 Nov 15. PLoS One. 2011. PMID: 22110765 Free PMC article.
Prevalence and patterns of HIV transmitted drug resistance in Guatemala.
Avila-Ríos S, Mejía-Villatoro CR, García-Morales C, Soto-Nava M, Escobar I, Mendizabal R, Girón A, García L, Reyes-Terán G. Avila-Ríos S, et al. Rev Panam Salud Publica. 2011 Dec;30(6):641-8. doi: 10.1590/s1020-49892011001200024. Rev Panam Salud Publica. 2011. PMID: 22358416
HIV-1 drug resistance surveillance in antiretroviral treatment-naive individuals from a reference hospital in Guatemala, 2010-2013.
Avila-Ríos S, García-Morales C, Garrido-Rodríguez D, Tapia-Trejo D, Girón-Callejas AC, Mendizábal-Burastero R, Escobar-Urias IY, García-González BL, Navas-Castillo S, Pinzón-Meza R, Mejía-Villatoro CR, Reyes-Terán G. Avila-Ríos S, et al. AIDS Res Hum Retroviruses. 2015 Apr;31(4):401-11. doi: 10.1089/aid.2014.0057. Epub 2014 Oct 27. AIDS Res Hum Retroviruses. 2015. PMID: 25347163
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.
Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, Rinke de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW. Rhee SY, et al. PLoS Med. 2015 Apr 7;12(4):e1001810. doi: 10.1371/journal.pmed.1001810. eCollection 2015 Apr. PLoS Med. 2015. PMID: 25849352 Free PMC article.
HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes.
Mendoza Y, Castillo Mewa J, Martínez AA, Zaldívar Y, Sosa N, Arteaga G, Armién B, Bautista CT, García-Morales C, Tapia-Trejo D, Ávila-Ríos S, Reyes-Terán G, Bello G, Pascale JM. Mendoza Y, et al. PLoS One. 2016 Apr 27;11(4):e0154317. doi: 10.1371/journal.pone.0154317. eCollection 2016. PLoS One. 2016. PMID: 27119150 Free PMC article.
Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey.
Ávila-Ríos S, García-Morales C, Matías-Florentino M, Romero-Mora KA, Tapia-Trejo D, Quiroz-Morales VS, Reyes-Gopar H, Ji H, Sandstrom P, Casillas-Rodríguez J, Sierra-Madero J, León-Juárez EA, Valenzuela-Lara M, Magis-Rodríguez C, Uribe-Zuñiga P, Reyes-Terán G; HIVDR MexNet Group. Ávila-Ríos S, et al. Lancet HIV. 2016 Dec;3(12):e579-e591. doi: 10.1016/S2352-3018(16)30119-9. Epub 2016 Sep 14. Lancet HIV. 2016. PMID: 27658867
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.
Gupta RK, Gregson J, Parkin N, Haile-Selassie H, Tanuri A, Andrade Forero L, Kaleebu P, Watera C, Aghokeng A, Mutenda N, Dzangare J, Hone S, Hang ZZ, Garcia J, Garcia Z, Marchorro P, Beteta E, Giron A, Hamers R, Inzaule S, Frenkel LM, Chung MH, de Oliveira T, Pillay D, Naidoo K, Kharsany A, Kugathasan R, Cutino T, Hunt G, Avila Rios S, Doherty M, Jordan MR, Bertagnolio S. Gupta RK, et al. Lancet Infect Dis. 2018 Mar;18(3):346-355. doi: 10.1016/S1473-3099(17)30702-8. Epub 2017 Dec 5. Lancet Infect Dis. 2018. PMID: 29198909 Free PMC article.
119 results